Your browser doesn't support javascript.
loading
Obesity mediates the opposite association of education and diabetes in Chinese men and women: Results from the REACTION study.
Zhu, Yuanyue; Hu, Chunyan; Lin, Lin; Wang, Shuangyuan; Lin, Hong; Huo, Yanan; Wan, Qin; Qin, Yingfen; Hu, Ruying; Shi, Lixin; Su, Qing; Yu, Xuefeng; Yan, Li; Qin, Guijun; Tang, Xulei; Chen, Gang; Xu, Min; Xu, Yu; Wang, Tiange; Zhao, Zhiyun; Gao, Zhengnan; Wang, Guixia; Shen, Feixia; Luo, Zuojie; Chen, Li; Li, Qiang; Ye, Zhen; Zhang, Yinfei; Liu, Chao; Wang, Youmin; Wu, Shengli; Yang, Tao; Deng, Huacong; Chen, Lulu; Zeng, Tianshu; Zhao, Jiajun; Mu, Yiming; Wang, Weiqing; Ning, Guang; Bi, Yufang; Chen, Yuhong; Lu, Jieli.
Afiliación
  • Zhu Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hu C; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumors, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong Univer
  • Lin L; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang S; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumors, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong Univer
  • Lin H; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Huo Y; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumors, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong Univer
  • Wan Q; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Qin Y; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumors, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong Univer
  • Hu R; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shi L; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumors, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong Univer
  • Su Q; Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
  • Yu X; The Affiliated Hospital of Luzhou Medical College, Luzhou, China.
  • Yan L; The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Qin G; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Tang X; Affiliated Hospital of Guiyang Medical University, Guiyang, China.
  • Chen G; Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Xu M; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xu Y; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Wang T; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhao Z; The First Hospital of Lanzhou University, Lanzhou, China.
  • Gao Z; Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
  • Wang G; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shen F; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumors, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong Univer
  • Luo Z; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen L; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumors, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong Univer
  • Li Q; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Ye Z; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumors, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong Univer
  • Zhang Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Liu C; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumors, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong Univer
  • Wang Y; Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, China.
  • Wu S; The First Hospital of Jilin University, Changchun, China.
  • Yang T; The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Deng H; The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Chen L; Qilu Hospital of Shandong University, Jinan, China.
  • Zeng T; The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhao J; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Mu Y; Central Hospital of Shanghai Jiading District, Shanghai, China.
  • Wang W; Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China.
  • Ning G; The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Bi Y; Karamay Municipal People's Hospital, Xinjiang, China.
  • Chen Y; The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Lu J; The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
J Diabetes ; 14(11): 739-748, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36217863
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus / Obesidad Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus / Obesidad Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia